Billerica, Massachusetts, May 10, 2016 — MilliporeSigma will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.
Innovatons that enable faster, easier and more reliable research, including the CellASIC™ ONIX 2 Microfluidic Platform, a tool for live cell analysis are among MilliporeSigma’s products on display at booth #A1408.
“MilliporeSigma’s new products exemplify our commitment to developing solutions that solve difficult challenges for our customers,” said Udit Batra, Member of the MilliporeSigma Executive Board and CEO, Life Science. “MilliporeSigma has a proven track record in life science and continues to innovate with our new CellASIC™ Platform.”
The CellASIC™ Platform allows researchers to monitor responses to perfusion, temperature and gas environment changes in live cells and track individual cell responses over time for truly dynamic cellular analysis. It also offers constant, stable imaging conditions while maintaining the health of cells, and combines the highest precision controls, superior functionality and simplest user interface for a unique live cell analysis experience.
MilliporeSigma will also showcase the following innovations at the show:
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 72 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $130 billion global life science industry.
Merck KGaA, Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of €12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.
Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck KGaA, Darmstadt, Germany operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the U.S. and Canada.